NZ208441A - Steroids and pharmaceutical compositions - Google Patents

Steroids and pharmaceutical compositions

Info

Publication number
NZ208441A
NZ208441A NZ208441A NZ20844184A NZ208441A NZ 208441 A NZ208441 A NZ 208441A NZ 208441 A NZ208441 A NZ 208441A NZ 20844184 A NZ20844184 A NZ 20844184A NZ 208441 A NZ208441 A NZ 208441A
Authority
NZ
New Zealand
Prior art keywords
group
compound
general formula
hydroxy
methyl
Prior art date
Application number
NZ208441A
Other languages
English (en)
Inventor
G Neef
G Sauer
R Wiechert
S Beier
W Elger
D Henderson
R Rohde
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3321826A external-priority patent/DE3321826A1/de
Priority claimed from DE19843413036 external-priority patent/DE3413036A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NZ208441A publication Critical patent/NZ208441A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ208441A 1983-06-15 1984-06-15 Steroids and pharmaceutical compositions NZ208441A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3321826A DE3321826A1 (de) 1983-06-15 1983-06-15 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19843413036 DE3413036A1 (de) 1984-04-04 1984-04-04 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
NZ208441A true NZ208441A (en) 1988-01-08

Family

ID=25811539

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ208441A NZ208441A (en) 1983-06-15 1984-06-15 Steroids and pharmaceutical compositions

Country Status (16)

Country Link
EP (1) EP0129499B1 (enrdf_load_stackoverflow)
JP (1) JPH02167296A (enrdf_load_stackoverflow)
AU (1) AU572849B2 (enrdf_load_stackoverflow)
CA (1) CA1307784C (enrdf_load_stackoverflow)
DD (1) DD218624A5 (enrdf_load_stackoverflow)
DE (1) DE3468030D1 (enrdf_load_stackoverflow)
DK (1) DK166729B1 (enrdf_load_stackoverflow)
ES (1) ES533260A0 (enrdf_load_stackoverflow)
FI (1) FI78709C (enrdf_load_stackoverflow)
GR (1) GR82210B (enrdf_load_stackoverflow)
HU (1) HU191131B (enrdf_load_stackoverflow)
IE (1) IE57620B1 (enrdf_load_stackoverflow)
IL (1) IL72085A (enrdf_load_stackoverflow)
NO (1) NO160521C (enrdf_load_stackoverflow)
NZ (1) NZ208441A (enrdf_load_stackoverflow)
PT (1) PT78732B (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5494914A (en) * 1992-05-21 1996-02-27 Endorecherche Inhibitors for testosterone 5α-reductase activity
US5593981A (en) * 1989-07-07 1997-01-14 Endorecherche Inc. Method and treatment of androgen-related diseases
US6110906A (en) * 1989-03-10 2000-08-29 Endorecherche, Inc. Androgen derivatives for use in the inhibition of sex steroid activity

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446661A1 (de) * 1984-12-18 1986-06-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 13(alpha)-alkyl-17(beta)-(3-acyloxypropyl)-gonane
DE3506785A1 (de) * 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3630030A1 (de) * 1986-09-01 1988-03-03 Schering Ag 13(alpha)-alkylgonan-(delta)(pfeil hoch)9(pfeil hoch)(pfeil hoch)((pfeil hoch)(pfeil hoch)1(pfeil hoch)1(pfeil hoch))(pfeil hoch)-5,10-epoxide
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
BE1004905A4 (fr) * 1987-12-30 1993-02-23 Roussel Uclaf Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE59010853D1 (de) * 1989-08-04 1998-12-03 Schering Ag 11 Beta-Aryl-gona-4,9-dien-3-one
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4008584A1 (de) * 1990-03-15 1991-09-26 Schering Ag Verfahren zur herstellung von zwischenprodukten fuer die antigestagensynthese (onapristonsynthese)
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
DE59108700D1 (de) * 1990-08-18 1997-06-12 Schering Ag Verfahren zur herstellung von 17-oxosteroiden
US5472854A (en) * 1990-08-18 1995-12-05 Schering Aktiengesellschaft Process for the production of 17-oxosteroids via the fermentative oxidation of 17β-hydroxysteroids by Mycobacterium
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4415590A1 (de) * 1994-04-28 1995-11-02 Schering Ag Verfahren zur stereoselektiven Einführung einer Alkinylseitenkette an 11ß-Aryl-substituierten 13alpha-Alkylgonan-17-onen
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
RU2129125C1 (ru) * 1995-04-06 1999-04-20 Украинский научно-исследовательский институт фармакотерапии эндокринных заболеваний СПОСОБ ПОЛУЧЕНИЯ 13α--1,3,510-ТРИЕН-19-НОРАНДРОСТАН-3-ОЛ-17-ОНА И ЕГО МЕТИЛОВОГО ЭФИРА
CA2668824A1 (en) 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secre Tary Of The Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
WO2016081383A1 (en) 2014-11-17 2016-05-26 Arno Therapeutics, Inc. Onapristone extended-release compositions and methods
CA2998924A1 (en) * 2015-09-25 2017-03-30 Context Biopharma Inc. Methods of making onapristone intermediates
US10548905B2 (en) 2015-12-15 2020-02-04 Context Biopharma Inc. Amorphous onapristone compositions and methods of making the same
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
CA1304916C (en) * 1984-10-18 1992-07-14 Wilhelm Bannwarth Apparatus for the parallel performance of a plurality of chemical reaction sequences

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5585405A (en) * 1989-03-10 1996-12-17 Endorecherche Inc. Inhibitors of sex steroid biosynthesis and methods for their production and use
US6110906A (en) * 1989-03-10 2000-08-29 Endorecherche, Inc. Androgen derivatives for use in the inhibition of sex steroid activity
US5593981A (en) * 1989-07-07 1997-01-14 Endorecherche Inc. Method and treatment of androgen-related diseases
US5610150A (en) * 1989-07-07 1997-03-11 Endorecherche Inc. Method of treatment of androgen-related diseases
US5494914A (en) * 1992-05-21 1996-02-27 Endorecherche Inhibitors for testosterone 5α-reductase activity

Also Published As

Publication number Publication date
EP0129499A2 (de) 1984-12-27
IE57620B1 (en) 1993-02-10
ES8502612A1 (es) 1985-02-01
PT78732A (pt) 1985-01-01
IE841484L (en) 1984-12-15
DK288184A (da) 1984-12-16
FI78709C (fi) 1989-09-11
GR82210B (enrdf_load_stackoverflow) 1984-12-13
PT78732B (de) 1986-06-03
JPH02167296A (ja) 1990-06-27
NO160521C (no) 1989-04-26
DK166729B1 (da) 1993-07-05
JPH0369919B2 (enrdf_load_stackoverflow) 1991-11-05
FI842395A0 (fi) 1984-06-13
IL72085A0 (en) 1984-10-31
EP0129499B1 (de) 1987-12-09
IL72085A (en) 1987-09-16
DK288184D0 (da) 1984-06-12
ES533260A0 (es) 1985-02-01
NO160521B (no) 1989-01-16
FI842395A7 (fi) 1984-12-16
HUT36139A (en) 1985-08-28
DE3468030D1 (en) 1988-01-21
HU191131B (en) 1987-01-28
FI78709B (fi) 1989-05-31
EP0129499A3 (en) 1985-10-09
DD218624A5 (de) 1985-02-13
CA1307784C (en) 1992-09-22
AU2936184A (en) 1984-12-20
AU572849B2 (en) 1988-05-19
NO842394L (no) 1984-12-17

Similar Documents

Publication Publication Date Title
NZ208441A (en) Steroids and pharmaceutical compositions
US4536401A (en) 11β-aryl estradienes, processes for their production and pharmaceutical preparations containing them
FI85274B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 11 -(4-isopropenylfenyl) estra-4,9-diener.
FI85377B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 13-alkyl-11 -fenylgonaner.
EP0349481B1 (de) 13-Alkyl-11Beta-phenylgonane
EP0147361B1 (de) 11 Beta-Aryl-Estradiene, deren Herstellung und diese enthaltende pharmazeutische Präparate
JP2664390B2 (ja) 新規な１１−アリールステロイド誘導体
TWI413645B (zh) １８-甲基-１９-去甲雄甾-４-烯-１７，１７-螺醚（即１８-甲基-１９-去甲基-２０-螺氧-４-烯-３-酮）及含其之醫藥產品
US4921845A (en) 11-arylsteroid compounds
DE3921059A1 (de) 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
EP0360369A1 (de) 11Beta-phenyl-14betaH-steroide
Peters et al. 11. beta.-Nitrate estrane analogs: potent estrogens
JPS6041695A (ja) １３α−アルキルゴナン、その製造方法及び該化合物を含有する、抗ゲスタ−ゲン作用を有する製剤製品
DE3504421A1 (de) Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
CA2382489C (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
JPS60209600A (ja) １７―置換エストラジエン又はエストラトリエン及びその製法
EP0664811B1 (de) Gestagen wirksame 19,11-überbrückte 4-estrene
DE3413036A1 (de) 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate
CZ20024014A3 (cs) Steroidní derivát
WO1995027725A1 (de) 11β,19-ÜBERBRÜCKTE 13α-ALKYLSTEROIDE